Watch Ticker

Natera, Inc. Common Stock

Go to Natera, Inc. Common Stock Website

$134.58

0.00 (0.00%)

Live

Previous Close

$134.58

Day Range

$0 - $0

Previous Day Range

$131.8106 - $136.28

Market Cap

$18.4 billion USD

Day Vol.

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetu...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth

The U.S. minimal residual disease testing market is projected to reach $2020 million by 2033, growing at a 9.38% CAGR, driven by rising cancer rates and advancements in precision medicine technologies like NGS and flow cytometry.

Related tickers: TWST, TMO, ILMN, ADPT, NTRA.

Read Full Article

Researchandmarkets.Com - Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape

The report highlights the rapid advancements in the molecular diagnostics for cancer market, driven by trends like personalized medicine, pharmacogenomics, and liquid biopsy. It profiles over 140 companies and provides extensive data and forecasts to aid decision-making in this evolving global market.

Related tickers: TXG, ABT, A, EXAS, GH, ILMN, NTRA, QGEN, TMO.

Read Full Article

Trending Tickers

Please sign in to view